Groups urge incentives for antibiotic research
February 24, 2012
by Jaimy Lee
The Infectious Diseases Society of America and a coalition of groups representing patients, providers and others are advocating for the inclusion of economic incentives for antibiotic research and development in the reauthorization of the Prescription Drug User Fee Act.
“The simple fact is we haven't found the right combination of incentives to convince pharmaceutical companies to invest in developing the new antibiotics we desperately need, and PDUFA reauthorization is an opportunity to do so,” said Jeff Levi, executive director of the Trust for America's Health, an advocacy organization, in the news release. “Rich or poor, all of us are dependent on the development of effective new antibiotics.”
View the full story (some sites require registration)